Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Michael Gary Martin"'
Autor:
Soniya Dulal, Bishnu Dutta Paudel, Lori Anne Wood, Prakash Neupane, Aarati Shah, Bibek Acharya, Ramila Shilpakar, Sandhya Chapagain Acharya, Ambuj Karn, Bishal Poudel, Rameej Revanta Thapa, Albira Acharya, Michael Gary Martin
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1258-1263 (2020)
PURPOSE Patients with GI cancers in Nepal often present with advanced disease and poor outcomes. The purpose of the study was to determine the time to presentation, diagnosis, and treatment of GI cancer and the baseline factors that may be associated
Externí odkaz:
https://doaj.org/article/104c47ccc089441facc0776664495689
Publikováno v:
World Journal of Oncology
Personalized medicine (PM) has revolutionized oncology management in high human development indexed countries. By interrogating both disease and host factors through a variety of tools, oncologists have been able to better target an individual's canc
Autor:
Daniel A. Pollyea, Matthew J. Wieduwilt, Pankit Vachhani, Ivana Gojo, Dinesh S. Rao, Alice S. Mims, Dale L. Bixby, Jessica K. Altman, Alexander E. Perl, Jeffrey E. Lancet, Reza Nejati, Paul J. Shami, Richard Stone, Aric C. Hall, Mary Elizabeth Percival, Guido Marcucci, Kristina M. Gregory, Frederick R. Appelbaum, Jadee L. Neff, Gabriel N. Mannis, Meagan A. Jacoby, Farhad Ravandi-Kashani, Marcos de Lima, Rebecca L. Olin, James M. Foran, Martin S. Tallman, Stephen A. Strickland, Amir T. Fathi, Kendra Sweet, Amanda Przespolewski, Michael Gary Martin, Thomas Prebet, Vijaya Raj Bhatt, Ndiya Ogba
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:16-27
The NCCN Guidelines for Acute Myeloid Leukemia (AML) provide recommendations for the diagnosis and treatment of adults with AML based on clinical trials that have led to significant improvements in treatment, or have yielded new information regarding
Autor:
Alaa Altahan, Lindsay Kaye Morris, Martin D. Fleming, Jatin S. Gandhi, Upama Giri, John Mays, Michael Gary Martin
Publikováno v:
Journal of Surgical Oncology. 123:687-692
Background Data about the impact of surgical margin positivity on patient outcomes following radical nephrectomy (RN) for renal cell carcinoma (RCC) is limited. We evaluate the effect of positive surgical margins (PSMs) on relapse-free survival (RFS)
Autor:
Lori Wood, Rameej Revanta Thapa, Ramila Shilpakar, Aarati Shah, Prakash Neupane, Ambuj Karn, Bishnu Dutta Paudel, Bishal Poudel, Michael Gary Martin, Albira Acharya, Soniya Dulal, Sandhya Chapagain Acharya, Bibek Acharya
Publikováno v:
JCO Global Oncology
PURPOSE Patients with GI cancers in Nepal often present with advanced disease and poor outcomes. The purpose of the study was to determine the time to presentation, diagnosis, and treatment of GI cancer and the baseline factors that may be associated
Publikováno v:
Anticancer Research. 40:5423-5426
BACKGROUND/AIM Exposure to pesticides has been reportedly associated with several types of cancer. MATERIALS AND METHODS In this study, we used data from The United States Geological Survey (USGS), United States Census, and the Surveillance, Epidemio
Autor:
Philip A. Philip, Benjamin W. Deschner, Joanne Xiu, John L. Marshall, Michael Gary Martin, Miriam W. Tsao, Matthew K Stein, Heinz-Josef Lenz, Forrest W Williard, Evan S. Glazer, Jeremiah L. Deneve, Danny Yakoub, Axel Grothey, W. Michael Korn, David Shibata, Anthony F. Shields, Paxton V. Dickson, Jimmy J. Hwang
Publikováno v:
J Surg Oncol
BACKGROUND AND OBJECTIVES: Peritoneal metastases (PM) from primary colorectal cancer (pCRC) are associated with poor outcomes; however, molecular differences are not well defined. METHODS: We compared unpaired tumor profiles of patients with pCRC and
Autor:
Olayemi Olubunmi Dawodu, Adeoluwa Akeem Adeniji, Gabriel Timilehin Fagbenro, Ademola Oluwatosin Oyekan, Muhammad Yaqub Habeebu, Mariam Adebola Bashir, Samuel Olalekan Keshinro, Michael Gary Martin
Publikováno v:
World Journal of Oncology
Background: Breast cancer in African women differs from the Caucasian. Understanding the profile of Nigerian women with breast cancer will help with preventive measures and treatment. This study focused on the clinico-pathological characteristics, wi
Autor:
Joanne Xiu, Sandeep Mittal, Amy B. Heimberger, Jeff Swensen, Andrew Brenner, Matthew K Stein, Manjari Pandey, Hongseok Tae, Michael Gary Martin, W. Michael Korn
Publikováno v:
JCO Precision Oncology. :1-13
PURPOSE Tumor mutational burden (TMB) is a developing biomarker in non–small-cell lung cancer (NSCLC). Little is known regarding differences between TMB and sample location, histology, or other biomarkers. METHODS A total of 3,424 unmatched NSCLC s
Publikováno v:
JCO Precision Oncology. :1-3